Thromboprophylaxis for Children Post‐Fontan Procedure: Insights From the UNIVERSE Study
Brian W. McCrindle(University of Toronto), Benjamin E. Reinking, Nagib Dahdah(HTC (Taiwan)), Jennifer S. Li(Duke University), Juan Pablo Sandoval(Instituto Nacional de Cardiología), Dimpna C. Albert, John L. Jefferies(St. Luke's Episcopal Hospital), Jun Muneuchi, Hiroshi Ono, Haleh Heydarian, Biagio A. Pietra, Jonathan Cramer, Guillermo Chantada, Kevin C. Harris(BC Children's Hospital), Kimberly Nessel(Janssen (United States)), Henri Justino(Rady Children's Hospital-San Diego), Wentao Lu(Janssen (United States)), Kevin Hill(BC Children's Hospital), Andrew H. Van Bergen(Advocate Children's Hospital), Alan D. Michelson(University of Nottingham), Maria Angélica Binotto, H. Wéber(Johannes Gutenberg University Mainz), Juan Alejos(Instituto Nacional de Cardiología), Johannes M. P. J. Breur, Fernando Moya Rueda, Koichi Sagawa, Hasri Samion, Robert A. Niebler, Liza Miriam Pina(Janssen (United States)), Andrew Van Bergen(Advocate Children's Hospital), Colleen Peluso(Janssen (United States)), Estela Suzana Kleiman Horowitz, Alejandro Peirone, Teresa Álvarez, Marie E. Steiner, Keisuke Sato, Federico Gutierrez‐Iarraya, Andrea Wirich Lenzi, Alexis Palacios, Shaji C. Menon, Joseph Rossano, Sergio Escribano Ruiz
Cited by 92
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
|Circulation|2007|877
The Agenda for Familial Hypercholesterolemia
|Circulation|2015|726
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
|The Lancet|2009|723
Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents
|Hypertension|2009|633